Speaker: Marc S. Raab, MD (he/him/his) – Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
### he/him/his @@@ Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research ### 1395074###Speaker###Research Team Leader and Consultant Haematologist###The Institute of Cancer Research###Speaker: Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research
###Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
### @@@ Mehmet K. Samur, PhD – Dana-Farber Cancer Institute ### 1395042###Speaker###Senior Research Scientist###Dana-Farber Cancer Institute###Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute
###Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
### @@@ Mattia D'Agostino, MD – University of Turin ### 1949896###Speaker###Assistant professor###University of Turin###Speaker: Mattia D'Agostino, MD – University of Turin
###Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US
### @@@ Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino ### 1441897###Co-Chair###Professor / Hematologist###Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino###Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
###Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
### she/her/hersSpeaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
###